Omar Salihi-Al

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Does pattern of 5-aminolevulinic acid (5-ALA) residual intra-operatively predict worse outcome in glioblastoma?

Does pattern of 5-aminolevulinic acid (5-ALA) residual intra-operatively predict worse outcome in glioblastoma?

Journal: Brain & spine
Published: April 21, 2026

Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology.

Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology.

Journal: Pathology oncology research : POR
Published: February 13, 2026

Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.

Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 08, 2026

Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.

Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.

Journal: Cancers
Published: November 28, 2025

Antiepileptic drugs in glioblastoma survival: dichotomic or treatment and mechanism of action-dependent variable?

Antiepileptic drugs in glioblastoma survival: dichotomic or treatment and mechanism of action-dependent variable?

Journal: Neuro-oncology advances
Published: October 01, 2025

Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.

Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.

Journal: BMJ open
Published: March 08, 2024

MGMT Promoter Methylation: Prognostication beyond Treatment Response.

MGMT Promoter Methylation: Prognostication beyond Treatment Response.

Journal: Journal of personalized medicine
Published: May 07, 2023

Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.

Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.

Journal: British journal of cancer
Published: August 17, 2021

Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic.

Patient-reported Experience Measure for Neuro-oncology Telephone Clinics during the COVID-19 Pandemic.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: August 04, 2020

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026